 |
PDBsum entry 4bzb
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of the tetrameric dgtp-bound samhd1 mutant catalytic core
|
|
Structure:
|
 |
Deoxynucleoside triphosphate triphosphohydrolase samhd1. Chain: a, b, c, d. Fragment: hd domain, residues 113-626. Synonym: dntpase, dendritic cell-derived ifng-induced protein, dcip, monocyte protein 5, mop-5, sam domain and hd domain-containing protein 1, samhd1. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008. Expression_system_variant: rosetta 2.
|
|
Resolution:
|
 |
|
1.83Å
|
R-factor:
|
0.190
|
R-free:
|
0.206
|
|
|
Authors:
|
 |
X.Ji,H.Yang,Y.Wu,J.Yan,J.Mehrens,M.Delucia,C.Hao,A.M.Gronenborn, J.Skowronski,J.Ahn,Y.Xiong
|
|
Key ref:
|
 |
X.Ji
et al.
(2013).
Mechanism of allosteric activation of SAMHD1 by dGTP.
Nat Struct Biol,
20,
1304-1309.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
25-Jul-13
|
Release date:
|
23-Oct-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9Y3Z3
(SAMH1_HUMAN) -
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
626 a.a.
481 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
20:1304-1309
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mechanism of allosteric activation of SAMHD1 by dGTP.
|
|
X.Ji,
Y.Wu,
J.Yan,
J.Mehrens,
H.Yang,
M.DeLucia,
C.Hao,
A.M.Gronenborn,
J.Skowronski,
J.Ahn,
Y.Xiong.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
SAMHD1, a dNTP triphosphohydrolase (dNTPase), has a key role in human innate
immunity. It inhibits infection of blood cells by retroviruses, including HIV,
and prevents the development of the autoinflammatory Aicardi-Goutières syndrome
(AGS). The inactive apo-SAMHD1 interconverts between monomers and dimers, and in
the presence of dGTP the protein assembles into catalytically active tetramers.
Here, we present the crystal structure of the human tetrameric SAMHD1-dGTP
complex. The structure reveals an elegant allosteric mechanism of activation
through dGTP-induced tetramerization of two inactive dimers. Binding of dGTP to
four allosteric sites promotes tetramerization and induces a conformational
change in the substrate-binding pocket to yield the catalytically active enzyme.
Structure-based biochemical and cell-based biological assays confirmed the
proposed mechanism. The SAMHD1 tetramer structure provides the basis for a
mechanistic understanding of its function in HIV restriction and the
pathogenesis of AGS.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |